NIH Common Fund Expanding
July 30th, 2014 by Rebecca Norman
The National Institutes of Health has selected several new programs for its Common Fund to capitalize on new areas of biomedical research, the agency has announced.
The programs include work to facilitate the study of how sugar modifications affect proteins, to understand the arrangement of DNA within cells in four dimensions, and to enable the development of new therapies that allow control of organ function through manipulation of nerves, according to an NIH release.
“These programs tackle some of the most difficult and novel areas being confronted by the biomedical research community,” said James M. Anderson, M.D., Ph.D., director of the Division of Program Coordination, Planning, and Strategic Initiatives, which oversees the NIH Common Fund. “Each new program has the ability to catalyze biomedical advances and expand research in critical areas of human health.”
Common Fund programs are designed to pursue major opportunities and gaps in biomedical research that no single NIH institute could tackle alone, but that the agency as a whole can address to make the biggest impact possible on the progress of medical research.